Medicinal Cannabis Amend Course
Comprehensive education and audit program specifically designed for practitioners directed by AHPRA to complete remediation related to medicinal cannabis prescribing.

Approved Education
Tailored remediation course
Evidence-based guidance with addiction medicine specialist
One-on-one workshops
Legislation & guidelines, recording keeping & self auditing
Cannabis specific
Prescribing principles & practices Compliant Patient management
Telehealth regulations
Assesment & monitoring Real time monitoring systems
Course Timeline
Week 1
Preliminary review of your specific remediation requirements, creation of a personalised learning plan, and scheduling of mentoring sessions to align with your practice schedule.
Week 2
Program introduction, platform access and initial assessment of learning needs. You’ll receive all necessary materials and establish communication with your dedicated mentor.
Week 3-6
Completion of core educational modules and participation in scheduled mentoring sessions. Application of learning to your clinical practice with ongoing support from program educators.
Week 7-8
Final assessment and preparation of completion documentation suitable for AHPRA submission.
Comprehensive Program Components
The AMEND Course equips prescribers with the knowledge, skills, and judgement to prescribe unapproved medicinal cannabis products safely and compliantly. Grounded in AHPRA’s updated expectations and adult learning theory, the course integrates legal education, clinical frameworks, and behavioural change strategies.
Module 1 – Context & Compliance: The Evolution of Medicinal Cannabis Regulation
- Overview of prescribing trends and regulatory response
- Professional misconduct cases and lessons learnt
- Policy insights from RACGP, TGA, and AHPRA
Module 2 – Prescribing Unapproved Medicines: Legislation, Risk, and Responsibility
- SAS-B and Authorised Prescriber pathways
- Legal duties: informed consent, adverse events, PBS exclusions
- Ethical prescribing principles and audit readiness
Module 3 – Becoming an Authorised Prescriber
- Application requirements: clinical justification, ethics
- Navigating AP letters, dose limits, formulation guidance
- Special considerations for Schedule 8 THC-
containing products
Module 4 – Cannabis Use Disorder & Managing Patient Risk
- Recognising dependency, diversion, and misuse
- CUDIT-R and other clinical screening tools
- Exit strategies and non-pharmacological support
Module 5 – Foundations of Good Prescribing Practice
- Comprehensive assessments (mental health, substance use)
- Real-time prescription monitoring
- (SafeScript/ScriptCheck) Documentation standards and record-keeping protocols
Module 6 – Prescribing in a Digital Landscape Telehealth: what’s compliant, what’s not
- Patient identity, continuity of care, informed consent in digital settings
- Managing high-risk consultations remotely
Module 7 – Patient-Centred Care & Shared Decision Making
- Engaging patients in treatment planning Consent, education, and expectation management
- Monitoring efficacy and side effects ethically
Module 8 – Collaborative Practice & Professional Communication
- Referral pathways and co-management Communicating with GPs, pharmacists, and mental health providers
- Shared records and care continuity under privacy law
Confidential 1:1 Remediation Sessions
- One-on-one sessions with an Addiction Medicine Specialist and cannabis expert educators
- Deep dive into legislation, prescribing limits, and audit readiness
- Tailored education plans with documented evidence of remediation
Course Fee
- Comprehensive re-education
- Designed for practionioners
- Available in September
Register Your Interest
Limited Intake Per Cohort
To ensure personalised attention and high-quality education, we limit enrolment for each program cohort.
Submit your expression of interest today, and our team will contact you within two business day to discuss your specific needs and next steps.
The AMEND Course represents the most comprehensive solution available for practitioners facing AHPRA-directed remediation related to medicinal cannabis prescribing.
Our team of medical educators will guide you through every step of the process.
About the Partnership

The Medicinal Cannabis Amend Course (MCAC) has been developed through a collaboration between Meducate and Nativa.
By bringing together Meducate’s expertise in CPD-accredited practitioner education with Nativa’s focus on patient access, research, and regulatory compliance, the partnership ensures the program is both clinically relevant and aligned with current AHPRA and TGA requirements.
This joint approach provides practitioners with the knowledge, tools, and confidence to navigate the amended Authorised Prescriber pathway, safeguard their practice, and deliver safe, effective patient care.

Dr Ferghal Armstrong, MB BCh BAO, FRACGP, FAChAM, MRCGP
Addiction Medicine Specialist | Co-Founder, Meducate
Dr Ferghal Armstrong is a General Practitioner and Addiction Medicine Specialist (FAChAM) with extensive experience in addiction medicine, pharmacotherapy, and medical education. As CEO and Co-Founder of Meducate, he leads the development of CPD-accredited training for healthcare professionals and hosts the Cracking Addiction podcast, providing evidence-based insights into the science and treatment of addiction.

Bec Doyle, Registered Registered Nurse
Chief Executive Officer | Nativa
Rebecca “Bec” Doyle is Nativa’s Medical Expert and an award-winning Medical Science Liaison. With a background in nursing and over five years of experience, she delivers evidence-based education to clinicians on safe, compliant prescribing of medicinal cannabis within the Australian regulatory framework.

Liz Warburton, Naturopath
Product Expert | Nativa
Liz Warburton is Nativa’s Product Expert and a qualified Naturopath with extensive experience in the Australian medicinal cannabis industry. She specialises in pharmacy education, supply chain management, and product compliance, and is a passionate advocate for advancing safe and innovative healthcare solutions.